Healthlead Share Price

HL

THA598010009

Drug Retailers

End-of-day quote Thailand S.E. 14/09/2026			5-day change	1st Jan Change
4.500 ^THB	+0.45%		-2.17%	-37.50%

08-17	Healthlead Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-11	Healthlead Public Company Limited (SET:HL) announces an Equity Buyback for 6,000,000 shares, representing 2.21% for THB 42 million.	CI

Healthlead Public Company Limited is a Thailand-based company involved in the pharmacy business, distributing medicines, medical supplies, cosmeceuticals, supplements, medical devices, and other healthcare products. The Company is also engaged in the invention, development, import, and distribution of healthcare products. Its businesses include Icare Health and Healthiness. Icare Health business operates pharmacies that sell more than 10,000 stock-keeping units (SKUs) of medicines, medical supplies, cosmeceuticals, dietary supplements, medical equipment, and healthcare products. Its pharmacies operate under four brands: iCare, Pharmax, Vitaminclub, and Super Drug. The Healthiness business develops its products in collaboration with external researchers. These products and innovations are marketed under two brands: PRIME and Besuto. Its brands also include BOMSKIN. The Companyâ€™s subsidiaries are Icare Health Co., Ltd. and Healthiness Co., Ltd. It operates approximately 64 branches.

Employees

Sector

Drug Retailers

More about the company

Quotes

Date	Price	Change	Volume
13/09/26	THB 4.500	+0.45%	71,523
11/09/26	THB 4.480	-0.44%	88,517
10/09/26	THB 4.500	+0.45%	133,418
09/09/26	THB 4.480	-0.44%	71,610
08/09/26	THB 4.500	+0.45%	135,062

End-of-day quote Thailand S.E.

More quotes

Annual profits - Rate of surprise

Company calendar

Market Cap	1.14B 34.61M 29.82M 28.24M 25.59M 48.02M 3.31B 48.26M 335M 129M 1.68B 130M 127M 5.32B	P/E 2024	35.4x	P/E 2025	24.8x
Enterprise Value	912M 27.62M 23.79M 22.53M 20.42M 38.31M 2.64B 38.5M 268M 103M 1.34B 104M 101M 4.24B	EV / Sales 2024	1.27x	EV / Sales 2025	0.73x
Free-Float	21.21%	Yield 2024	1.67%	Yield 2025	3.06%

08-17	Healthlead Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-11	Healthlead Public Company Limited (SET:HL) announces an Equity Buyback for 6,000,000 shares, representing 2.21% for THB 42 million.	CI
05-07	Healthlead Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-07	Healthlead Public Company Limited authorizes a Buyback Plan.	CI
04-29	Healthlead Public Company Limited's Equity Buyback announced on December 8, 2025, has expired.	CI
03-09	Healthlead Public Company Limited Announces Retirement of Rathpong Ratanahirunya as Independent Director, Effective 24 April, 2026	CI
02-26	Healthlead Public Company Limited Announces Board Changes, Effective February 26, 2026	CI
02-26	Healthlead Public Company Limited Announces CEO Changes, Effective March 1, 2026	CI
02-25	Healthlead Public Company Limited announces Annual dividend, payable on May 15, 2026	CI
02-24	Healthlead Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2025	CI
12-08	Healthlead Public Company Limited (SET:HL) announces an Equity Buyback for 9,000,000 shares, representing 3.31% for THB 65 million.	CI
12-07	Healthlead Public Company Limited authorizes a Buyback Plan.	CI
11-19	Tranche Update on Healthlead Public Company Limited (SET:HL)'s Equity Buyback Plan announced on May 15, 2025.	CI

01/06/22	Healthlead Public : Changing of Chief Accountant	PU
22/04/22	Healthlead Public : To report the resolutions of the 2022 Annual General Meeting of Shareholders	PU
31/03/22	Healthlead Public : Publication of Invitation to the 2022 Annual General Meeting of Shareholders on the Company's Website	PU

1 day	+0.45%
1 week	-2.17%
Current month	-7.02%
1 month	-17.43%
3 months	-20.35%
6 months	-31.82%
Current year	-37.50%

1 week	4.46	4.6
1 month	4.46	5.55
Current year	4.46	7.35
1 year	4.46	8.45
3 years	4.46	12.7
5 years	4.46	32
10 years	4.46	32

Healthlead Share Price

Stocks

HL

THA598010009

Drug Retailers

Valuation: Healthlead

Chart: Healthlead

Latest news: Healthlead

Press Releases: Healthlead

Quotes and Performance

Price Extremes

Managers and Directors: Healthlead

Latest insider transactions

Other Drug Retailers

Financials

Company Profile

Quotes

Annual profits - Rate of surprise

Manager	Title	Age	Since
Supakorn Bhandhukanonda CEO	Chief Executive Officer	38	28/02/2026
Araya Tantanasin DFI	Director of Finance/CFO	56	31/12/2018
Sasithon Marukasonthi AUD	Comptroller/Controller/Auditor	-	31/08/2022

Director	Title	Age	Since
Apirudee Hemajutha CHM	Chairman	70	31/03/2020
Marayad Teeratomorn BRD	Director/Board Member	57	31/03/2020
Thanasak Kulrattanarak BRD	Director/Board Member	52	31/03/2020

Date	Insider	Type	Main position	Quantity	% Market Cap.	Importance
03/04/25	Supakorn Bhandhukanonda	Buy	Chief Executive Officer	42,800	0.0157%
02/04/25	Supakorn Bhandhukanonda	Buy	Chief Executive Officer	50,000	0.0184%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
HEALTHLEAD	+0.45%	-2.17%	-42.31%	-63.71%	34.46M
JD HEALTH INTERNATIONAL INC.	+0.17%	-6.10%	-49.82%	-16.65%	14.13B
MATSUKIYOCOCOKARA & CO.	+3.52%	-1.44%	-17.72%	-10.39%	6.33B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-0.66%	-4.46%	-57.20%	-34.78%	6.22B
YIFENG PHARMACY CHAIN CO., LTD.	+0.80%	-1.05%	-12.03%	-21.48%	4.06B
NAHDI MEDICAL COMPANY	-0.66%	-2.11%	-18.82%	-38.20%	3.16B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	+3.11%	-2.87%	+5.01%	-29.83%	3B
GUARDIAN PHARMACY SERVICES, INC.	+4.19%	+7.42%	+53.74%	-	2.76B
CLICKS GROUP LIMITED	-4.23%	-7.07%	-48.78%	-29.54%	2.7B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	-1.19%	+0.28%	-18.21%	-6.03%	2.49B
Average	+0.55%	-1.66%	-20.61%	-27.85%	4.49B
Weighted average by Cap.	+0.63%	-3.27%	-28.85%	-21.64%

	2024	2025
Net sales	2.01B 60.94M 52.5M 49.71M 45.06M 84.54M 5.82B 84.97M 590M 227M 2.96B 229M 224M 9.36B	2.27B 68.77M 59.25M 56.1M 50.85M 95.4M 6.57B 95.88M 666M 256M 3.34B 258M 253M 10.56B
Net income	78.26M 2.37M 2.04M 1.93M 1.75M 3.29M 227M 3.31M 22.97M 8.83M 115M 8.9M 8.71M 364M	77.86M 2.36M 2.03M 1.92M 1.74M 3.27M 225M 3.29M 22.86M 8.79M 115M 8.86M 8.66M 362M
Net Debt	-220M -6.67M -5.75M -5.44M -4.93M -9.25M -637M -9.3M -64.62M -24.85M -324M -25.05M -24.5M -1.02B	-231M -7M -6.03M -5.71M -5.17M -9.71M -668M -9.75M -67.79M -26.07M -340M -26.27M -25.7M -1.07B